Posted: Wed, April 6, 2016
Outstanding Professional Education Award, recognizes a faculty member or researcher for his/her contribution to the field of professional education at Georgia Tech.
Prospective BioID Students Tour State-of-the-Art Clinical and Medical Device Prototyping Facilities
Posted: Tues, March 29, 2016
Georgia Tech’s Master of Biomedical Innovation and Development (MBID) program hosted 28 prospective students from across the country for two days of fast-paced activities with ideal springtime weather. Graduates of this intensive one-year professional master’s program are exceptionally well-prepared to pursue and advance in the dynamic field of biomedical engineering devices and technology. In addition to the collaborative academic instruction in biomedical technology from two top-ranked institutions in engineering, the Georgia Institute of Technology, and medicine, Emory University’s School of Medicine, they also receive practical, hands-on clinical experience in Atlanta’s thriving biomedical industry.
“This was the annual recruitment event for the fourth BioID cohort of students offered admission into this highly competitive program. The program has gained recognition from the large to small size medical device industries as reflected by the excellent placement across various roles of past batch graduates in companies such as Medtronic, St Jude, Cook Medical, Halyard and others,” said Sathya Gourisankar, program director, and a 30-plus year veteran in the medical device industry.
After a mid-day check-in at the Georgia Tech Hotel and Conference Center, visiting prospective students were whisked by bus to Grady Memorial Hospital. Grady is best known for its premier level 1 trauma center, its top rated burn center, and The Marcus Stroke and Neuroscience Center. Opened in 1892, Grady is an internationally recognized teaching hospital located near Georgia Tech and serves the metro Atlanta area where 5.7 million people live.
Jeremy Ackerman, a faculty member of the master’s program and board certified emergency physician who works at Grady, gave the group an insider’s tour of Grady’s emergency suites at the hospital. During the tour, medivac helicopters were landing rooftop and transporting a patient into the emergency room, but the group was not privy to the emergency treatment for this patient.
On day two, the group assembled at Georgia Tech’s Technology Enterprise Park (TEP), Atlanta’s home for the biotech community where the MBID program is taught. Lifescience and biotech corporations located in the building include St. Jude Medical, CardioMems, Kemira, and CryoLife.
The day started with a MBID program overview delivered by various program faculty members, that included professors from Georgia Tech’s College of Engineering, the Scheller School of Business, Emory physicians, and biomedical industry veterans – most of whom had more than 30 years of biomedical industry experience.
A tour was given through the biomedical and innovation design machine shop and design studio, followed by an in depth question and answer student panel comprised of current and former students.
After lunch, the group toured St. Jude’s T3 translational lab facilities located next to the TEP building. St. Jude Medical turns to T3 Labs to recreate real world operating conditions for preclinical trials, as do other companies in the biomedical device industry. Where appropriate, MBID students get the chance to work with T3 labs during their studies and projects.
Their final stop was a tour of the Global Center for Medical Innovation (GCMI) located adjacent to the Georgia Tech campus. GCMI brings together core members of the medical device community, including universities, research centers, clinicians, established device companies, investors and startups, with the goal of accelerating the commercialization of innovative medical technology. GCMI is an independent, not-for-profit, full-service product development organization — the first and only one of its kind in the Southeast. Several former and current students of the MBID program work at GCMI, and provided a wealth of information to prospective students.
“The appeal of the Georgia Tech Master of Biomedical Innovation and Development program was its industry-focused program faculty. Nearly all of the professors have extensive in-depth, real-world medical device industry experience,” said Rosalee Celis, a prospective student and bioengineering graduate from the University of Illinois at Urbana-Champaign. “I was very impressed with the program and don’t believe many programs are setup the way the MBID program is. Not only was I accepted into the program for fall 2016 class, but going to Georgia Tech was my top choice.”
More photos can be found here.
Media Contacts:Walter Rich
Wallace H. Coulter Department of Biomedical Engineering
Georgia Institute of Technology
MBID Recruitment Event on March 4 - 5, 2015
Posted: Tue, February 24, 2015
MBID Recruitment Event on March 3 - 4, 2014
Posted: Thu, February 27, 2014
Georgia Tech Names Sathya Gourisankar to Direct New Biomedical Innovation and Development Program
Biomedical Engineer Brings 30 Years’ R&D Experience to New Master’s Degree Program
Posted: Thu, June 6, 2013
ATLANTA (June 6, 2013) – The Georgia Institute of Technology has named Sathya Gourisankar, Ph.D., as Director of the Master of Biomedical Innovation and Development (BioID) Degree Program. This new degree focuses education and clinical experience to transform unmet clinical needs into practical, usable technologies and products for improving patient care. The inaugural BioID class begins in Fall 2013 as part of the Wallace H. Coulter Department of Biomedical Engineering.
Gourisankar led the development and global commercialization of 10 significant medical device products for cardio-thoracic, abdominal surgical, peripheral arterial and ophthalmology clinical applications. His 30-year background in research and development (R&D) includes project management, pre-clinical and clinical biomaterials research, and regulatory submissions.
"Developing safe and effective medical devices calls for a unique blend of rigorous science, state-of-the-art innovation, regulatory compliance, quality assurance, ethical considerations and business interests. With the increasing demands of science, regulations and business being faced by the Medical Device industries, there is no better time than now for the launch of the BioID program. I am very excited to be involved with this unique program,” says Gourisankar.
As Director of the BioID program, Gourisankar will coordinate student recruitment and admissions, curriculum development, and program assessment with the Coulter Department’s Associate Chair for Graduate Studies, Professor Gilda Barabino. In addition, he will be responsible for adjunct faculty recruitment and industry outreach initiatives to provide support for BioID student projects and the department's multidisciplinary capstone design initiative.
Gourisankar earned a doctorate in biomaterials/chemical engineering from State University of New York (SUNY) in Buffalo, NY. His thesis focused on biomaterials, biocompatibility of implants, surface treatments and analysis. Prior to joining Georgia Tech, Gourisankar was a biomedical scientist at Meadox Medical and R&D manager at top medical device companies in the United States and abroad, including Alcon Laboratories, C.R. Bard and ITC in Bangalore, India.
The BioID program seeks to prepare students from multiple disciplines for careers in a wide range of medical specialties. Courses include: engineering design and development processes, FDA and ISO regulatory requirements, medical markets, clinical practice/protocols, strategy and planning, finance and economics, product costing, project management, ethics and sustainability. Graduates of this intensive 12-month master’s program will be well prepared to pursue and advance their careers in the field of biomedical engineering devices, technology development, and commercialization.
In 2012, U.S. News & World Report ranked the Coulter Department’s bachelor’s and Ph.D. biomedical engineering programs second in the nation. The BioID master’s program will build upon the strengths and global reputation of these existing programs.
For more information, please visit: bioid.gatech.edu
Posted: Tue, September 11, 2012
September 10, 2012 -- Applications for the fall semester are now being accepted for the new Master of Biomedical Innovation and Development (BioID) program at GA Tech. The program seeks to develop graduates focused on unmet clinical needs, innovations in “translational” development and the commercialization of new technologies for improved patient care and healthcare outcomes.
Georgia Tech Offers Master’s Degree in Biomedical Innovation and Development
Posted: Tue, June 26, 2012
The Georgia Institute of Technology announces a unique Master of Biomedical Innovation and Development (BioID) Degree. This new program, offered by the Wallace H. Coulter Department of Biomedical Engineering, focuses education and clinical experience to transform unmet biomedical and clinical needs into practical, usable technologies and products for improving patient care. The application process for admissions will open Sept. 1, 2012, for the first class to matriculate in August 2013. Ideal candidates for the BioID master’s program include early-career professionals in medical device or biomedicine-related industries; engineers seeking medical device specialization; and high-performing graduates from engineering disciplines. Graduates of this intensive 12-month master’s program will be exceptionally well prepared to pursue and advance their careers in the dynamic field of biomedical device engineering, technology development and commercialization.